Research Roundup: October ESC Congress Findings & Clinical Studies
Atorvastatin reduced major cardiovascular events by 30% in adults aged 70 and older without prior cardiovascular disease, diabetes, or dementia, according to clinical trial findings presented during the European Society ... Read More